Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Plasmalogens as a marker of elevated systemic oxidative stress in Parkinson's disease.

Literature DB >> 19575554

Plasmalogens as a marker of elevated systemic oxidative stress in Parkinson's disease.

Charalampos Dragonas, Thomas Bertsch, Cornel C Sieber, Thorolf Brosche.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2009 PMID： 19575554 DOI： 10.1515/CCLM.2009.205

Source DB: PubMed Journal: Clin Chem Lab Med ISSN： 1434-6621 Impact factor: 3.694

Keyword Cloud
Cited

× No keyword cloud information.

25 in total

Review 1. Therapeutic Efficacy of Plasmalogens for Alzheimer's Disease, Mild Cognitive Impairment, and Parkinson's Disease in Conjunction with a New Hypothesis for the Etiology of Alzheimer's Disease.

Authors: Takehiko Fujino; Md Shamim Hossain; Shiro Mawatari
Journal: Adv Exp Med Biol Date: 2020 Impact factor: 2.622

2. Study of telomere length and different markers of oxidative stress in patients with Parkinson's disease.

Authors: G Watfa; C Dragonas; T Brosche; R Dittrich; C C Sieber; C Alecu; A Benetos; R Nzietchueng
Journal: J Nutr Health Aging Date: 2011-04 Impact factor: 4.075

3. Plasmalogen Loss in Sepsis and SARS-CoV-2 Infection.

Authors: Daniel P Pike; Reagan M McGuffee; Elizabeth Geerling; Carolyn J Albert; Daniel F Hoft; Michael G S Shashaty; Nuala J Meyer; Amelia K Pinto; David A Ford
Journal: Front Cell Dev Biol Date: 2022-06-06

Review 4. Roles of endogenous ether lipids and associated PUFAs in the regulation of ion channels and their relevance for disease.

Authors: Delphine Fontaine; Sandy Figiel; Romain Félix; Sana Kouba; Gaëlle Fromont; Karine Mahéo; Marie Potier-Cartereau; Aurélie Chantôme; Christophe Vandier
Journal: J Lipid Res Date: 2020-04-07 Impact factor: 5.922

Review 5. From peroxisomal disorders to common neurodegenerative diseases - the role of ether phospholipids in the nervous system.

Authors: Fabian Dorninger; Sonja Forss-Petter; Johannes Berger
Journal: FEBS Lett Date: 2017-09-07 Impact factor: 4.124

10. Measurement of Ether Phospholipids in Human Plasma with HPLC-ELSD and LC/ESI-MS After Hydrolysis of Plasma with Phospholipase A1.

Authors: Shiro Mawatari; Seira Hazeyama; Takehiko Fujino
Journal: Lipids Date: 2016-07-07 Impact factor: 1.880

Plasmalogens as a marker of elevated systemic oxidative stress in Parkinson's disease.

Review 1. Therapeutic Efficacy of Plasmalogens for Alzheimer's Disease, Mild Cognitive Impairment, and Parkinson's Disease in Conjunction with a New Hypothesis for the Etiology of Alzheimer's Disease.

2. Study of telomere length and different markers of oxidative stress in patients with Parkinson's disease.

3. Plasmalogen Loss in Sepsis and SARS-CoV-2 Infection.

Review 4. Roles of endogenous ether lipids and associated PUFAs in the regulation of ion channels and their relevance for disease.

Review 5. From peroxisomal disorders to common neurodegenerative diseases - the role of ether phospholipids in the nervous system.

6. Lipidomics of Alzheimer's disease: current status.

7. Lipid classes and fatty acid patterns are altered in the brain of γ-synuclein null mutant mice.

8. Alkyl-glycerol rescues plasmalogen levels and pathology of ether-phospholipid deficient mice.

Review 9. Peroxisomes in brain development and function.

10. Measurement of Ether Phospholipids in Human Plasma with HPLC-ELSD and LC/ESI-MS After Hydrolysis of Plasma with Phospholipase A1.